APA

Zajicek J. P., Sanders H. P., Wright D. E., Vickery P. J., Ingram W. M., Reilly S. M., Nunn A. J., Teare L. J., Fox P. J. & Thompson A. J. (20051213). Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. : Journal of neurology, neurosurgery, and psychiatry.

Chicago

Zajicek J P, Sanders H P, Wright D E, Vickery P J, Ingram W M, Reilly S M, Nunn A J, Teare L J, Fox P J and Thompson A J. 20051213. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. : Journal of neurology, neurosurgery, and psychiatry.

Harvard

Zajicek J. P., Sanders H. P., Wright D. E., Vickery P. J., Ingram W. M., Reilly S. M., Nunn A. J., Teare L. J., Fox P. J. and Thompson A. J. (20051213). Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. : Journal of neurology, neurosurgery, and psychiatry.

MLA

Zajicek J P, Sanders H P, Wright D E, Vickery P J, Ingram W M, Reilly S M, Nunn A J, Teare L J, Fox P J and Thompson A J. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. : Journal of neurology, neurosurgery, and psychiatry. 20051213.